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Introduction: Neurons have the intrinsic capacity to produce insulin, similar to pancreatic cells. Adult neural stem
cells (NSCs), which give rise to functional neurons, can be established and cultured not only by intracerebral
collection, which requires difficult surgery, but also by collection from the olfactory bulb (OB), which is relatively
easy. Adult neurogenesis in the hippocampus (HPC) is significantly decreased in diabetes patients. As a result,
learning and memory functions, for which the HPC is responsible, decrease.
Methods: In the present study, we compared the effect of diabetes on neurogenesis and insulin expression in
adult NSCs. Adult NSCs were derived from the HPC or OB of streptozotocin-induced diabetic rats. Comparative
gene-expression analyses were carried out by using extracted tissues and established adult NSC cultures from the
HPC or OB in diabetic rats.
Results: Diabetes progression influenced important genes that were required for insulin expression in both
OB- and HPC-derived cells. Additionally, we found that the expression levels of several genes, such as voltage-gated
sodium channels, glutamate transporters, and glutamate receptors, were significantly different in OB and HPC cells
collected from diabetic rats.
Conclusions: By using identified diabetes-response genes, OB NSCs from diabetes patients can be used during
diabetes progression to monitor processes that cause neurodegeneration in the central nervous system (CNS).
Because hippocampal NSCs and OB NSCs exhibited similar gene-expression profiles during diabetes progression,
OB NSCs, which are more easily collected and established than HPC NSCs, may potentially be used for screening of
effective drugs for neurodegenerative disorders that cause malignant damage to CNS functions.
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Adult neuronal stem cells (NSCs) exist in the hippo-
campus (HPC), which is responsible for learning and
memory, and new neurons are continuously generated,
even in the adult brain [1-3]. Adult NSCs retain the self-
renewal ability characteristic of stem cells and can give
rise to three differentiation lineages: neurons, astrocytes,
and oligodendrocytes [4,5]. As shown in recent studies,
the typical neurogenic regions in the mammalian brain
are the HPC, the subventricular zone (SVZ), and the* Correspondence: t.warashina@aist.go.jp
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reproduction in any medium, provided the orolfactory bulb (OB), and adult NSC cultures can be es-
tablished from these regions. NSCs derived from the OB
have the potential to be used in therapeutic applications
because they are easily harvested without harm to the
patient [6,7].
The fate of multipotent NSCs is determined by diverse
extracellular signals, corresponding intrinsic transcrip-
tional factors, and epigenetic machineries. Insulin is an
important neuromodulator, contributing to neurobiolo-
gic processes, energy homeostasis, and cognitive func-
tion. Moreover, insulin increases the tolerance of mature
neurons to toxicity and has a protective function that
keeps the network functions of the neurons in an active
state [8,9]. Insulin plays a major role in controlling theLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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induction of undifferentiated NSCs to differentiate into
oligodendrocytes, which function in protecting neurons
[10]. Moreover, insulin promotes the function of fibro-
blast growth factor 2 (FGF-2), which has an important
role in maintaining NSCs in the undifferentiated state,
and also plays a major role in the stem cell self-renewal
stage (that is, it strongly activates stem cell proliferation
[1,11-14]).
In the presence of low levels of insulin, the proliferative
functions of undifferentiated stem cells are suppressed in
many organs. Insulin-mediated signal transduction regu-
lates multiple roles in the self-renewal and differentiation
pathways of adult stem cells. Diabetes impairs the func-
tion of hematopoietic stem cells [15], skeletal muscle stem
cells (satellite cells) [16,17], osteoblast stem cells [18], and
NSCs [19,20]. The diabetes-induced reduction in adult
neurogenesis has been detected mainly in the HPC, and
diabetes has been associated with a decline in the cog-
nitive functions of learning and memory. Not only are
diabetes patients at increased risk of contracting neuro-
degenerative diseases and psychiatric disorders, such as
Alzheimer disease, Parkinson disease, depression, and
Huntington disease [19,21,22], but diabetes has also been
experimentally shown to have a great effect on the func-
tions of the neural circuits in the HPC [8,23,24]. Strep-
tozotocin (STZ)-induced diabetes produces a dramatic
decrease in cell proliferation in the hippocampal dentate
gyrus (DG) of rodents, and a significant decrease in the
number of BrdU(+) cells has been detected 2 days after
STZ-induction [25], suggesting that the effects of decrea-
sing insulin-mediated NSC regulation during diabetes
progression are acute. Reductions in NSC proliferation
have been observed not only in the HPC but also in the
SVZ [26].
Although recent studies indicate that anosmia is asso-
ciated with diabetes [27] and that insulin can modulate
olfactory processing for the OB network [28], the effect
of diabetes (that is, the decline in insulin regulation) on
OB NSC fate determination and potential genes involved
in the insulin-dependent regulation of OB NSCs are
unknown.
We recently demonstrated that adult OB and HPC
NSCs collected from diabetic rats are useful cell sources
for autologous cell transplantation to treat diabetes be-
cause they retain the intrinsic ability to produce insulin
in the adult CNS [29]. In this study, we examined the
changes in gene expression required for neuronal diffe-
rentiation and insulin expression in adult OB NSCs du-
ring diabetes progression. The properties of OB NSCs in
response to diabetes pathogenesis were compared with
those of HPC NSCs. Identification of genes that are
similarly altered in the HPC and OB during the progres-
sion of diabetes would be useful to monitor and/or toinvestigate the functions of cells in the HPC during dia-
betes progression in the clinical setting, because OB NSCs
can be easily collected and cultured from patients.
Materials and methods
Animals
Experiments were carried out on 30 Fischer 344 male
rats (about 4 months old) weighing 120 to 160 g. Dia-
betes mellitus was induced in 14 animals by single intra-
peritoneal injection of 50 mg/kg streptozotocin (Wako,
Osaka, Japan) dissolved in 0.5 ml of citrate buffer (0.1
M, pH 4.5). The blood glucose levels were measured
every 1 to 2 days, and rats with blood glucose levels
greater than 300 mg/dl were considered diabetic [29].
Rats of the experimental group were injected with
streptozotocin, and animals of the control group (n = 7)
were injected with an analogous volume of citrate buffer.
Tissue samples for expression-profile studies were
collected at 5 days, 2 weeks, and 2 months of strep-
tozotocin-induced diabetes. Animals were anesthetized
with pentobarbital sodium (70 to 100 mg/kg), and then
transcardially perfused sequentially with phosphate buf-
fer (0.1 M) and 4% PFA solution. All animal procedures
were performed according to a protocol approved by the
Institutional Animal Care and Use Committee (IACUC)
of the National Institute of Advanced Industrial Science
and Technology.
Cell preparation and the culture
Male Fisher 344 rats with a body weight of 100 to 150 g
10 days after the streptozotocin induction were used
(Charles River Japan, Inc, Yokohama, Japan). Adult hippo-
campal NSCs were prepared and maintained as described
previously [2,29]. Rats were anesthetized, and the head
was fixed in a stereotactic frame. The olfactory bulb (OB)
(AP4.2; L1.0; U2.5) and hippocampal dentate gyrus (DG)
(AP −3.6; −L2.8; U3.0) were taken. Tissue samples were
transferred to ice-cold PBS solution (Wako). Collected
HPC or OB was microdissected and dissociated by diges-
tion with a mixture of papain (Worthington Biochemical
Corporation, NJ, USA), dispase (Worthington Biochemical
Corporation, NJ, USA), deoxyribonuclease (Worthington),
and StemPro Accutase (Invitrogen). The cell mixture was
passed through a 40-μm cell strainer (BD Falcon, Tokyo,
Japan) to obtain a single-cell suspension. The resulting
cell suspension was washed with Dulbecco modified
Eagle medium/F-12 medium (DMEM/F12; Invitrogen,
Life Technologies Japan Ltd., Tokyo, Japan), including
antibiotic-antimycotic and FGF2, several times after
centrifugation. Purified HPC or OB cells were incubated
in DMEM/F12 containing 100 ng/ml FGF-2 and N2
Supplement with Transferrin (Apo, Wako) on poly-
ornithine-laminin-coated dishes that had been deter-
mined to be suitable for culturing both OB NSCs and
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levels of FGF2 (100 ng/ml) during the initial culture
before the first passage with StemPro Accutase. Stably
proliferating NSCs were cultured with DMEM/F12
containing 20 ng/ml FGF2, 1% N2 supplement, 1%
antibiotic-antimycotic, and 2 mM L-glutamine in a 5%
CO2 incubator at 37°C.
We cultured adult HPC and OB NSCs simultaneously
under FGF2 in all experiments performed in this parallel
characterization study. For neuronal differentiation, cells
were cultured in DMEM/F12 medium containing reti-
noic acid (RA) (1 μM, Sigma-Aldrich Japan K.K., Tokyo,
Japan), forskolin (5 μM, Sigma-Aldrich Japan K.K.,
Tokyo, Japan) and KCl (40 mM, Wako).
Western blotting and immunoprecipitation
The sample was homogenized in lysis buffer (50 mM
Hepes, pH 7.4, 150 mM NaCl, 2 mM EDTA, 1% sodium
deoxycholate, 1% NP-40, 0.2% sodium dodecylsulfate)
containing a phosphatase inhibitor and protease in-
hibitor mix (Nakarai Tesque Inc., Kyoto, Japan) on
ice. Protein concentrations were measured by using a
BCA protein-assay kit (Thermo Fisher Scientific K.K.,
Kanagawa, Japan). Each homogenized sample was di-
luted with SDS-PAGE loading buffer (62.5 mM Tris–
HCl, pH 6.8, 2% wt/vol SDS, 10% glycerol, 50 mM
β-mercaptoethanol, 0.01% wt/vol bromophenol blue) to
2.0 mg/ml, and an equivalent volume of each sample
was loaded onto 5% to 20% polyacrylamide gel (Wako
Pure Chemical Industries, Ltd., Osaka, Japan). An elec-
trically blotted PVDF membrane (Nihon Millipore,
Tokyo, Japan) was subjected to blocking with Blocking
One (Nakarai Tesque Inc.) for 1 hour at room tempera-
ture. Antibodies against SCN1B (Abcam, Tokyo, Japan)
and Neurexin I (BD Japan, Tokyo, Japan) were diluted
1:5,000 with TBS containing 0.05% Tween 20 (TBST)
and used as the primary antibodies, and incubation was
performed for 12 hours at 4°C. Anti-rabbit or anti-
mouse IgG-conjugated HRP (GE Healthcare Japan,
Tokyo, Japan), diluted 1:50,000 with blocking buffer, was
used as the secondary antibody, and incubation was
performed for 1 hour at room temperature. After incu-
bation with SuperSignal West Femto Maximum Sensitiv-
ity Substrate (Thermo Scientific Japan, Yokohama,
Japan), the result was imaged by using the LAS-3000
Imaging system (Fuji Film Corporation, Tokyo, Japan).
After a careful wash with blocking buffer, SuperSignal
West Femto Maximum Sensitivity Substrate (Thermo
Scientific Japan, Yokohama, Japan) was used as the
chromogen. The bands on the PVDF membrane were
analyzed by using NIH Image J.
For immunoprecipitation (IP) analysis, collected tissue-
derived lysates were washed twice with PBS and then
resuspended in IP-lysis buffer (50 mM HEPES/KOH, pH7.5, 50 mM potassium acetate, 8 mM MgCl2, 2 mM
EGTA, and 50 μg/ml digitonin) on ice for 10 minutes. To
prepare Protein G agarose (Millipore), the beads were
washed twice with PBS and restored to a 50% slurry with
PBS. The lysate was pre-cleared by adding 100 μl of G
agarose bead slurry (50%) per 1.5 ml of lysate and incuba-
ting at 4°C for 10 minutes on an orbital shaker, and the
Protein G beads were removed by centrifugation at 14,000
g at 4°C for 10 minutes. The supernatant was transferred
to a fresh centrifuge tube as the pre-cleaned fraction. The
fractions were incubated overnight at 4°C with 20 μl of
normal rabbit serum in binding buffer (20 mM Tris–HCl,
pH 7.5, 60 mM KCl, 2.5 mM EDTA, and 0.1% Triton
X-100) and suspended with protein G-agarose beads.
After removal of the nonspecific binding fraction to beads
by precipitation, the resulting supernatant lysate was
mixed with 100 μl of protein G-agarose beads plus 1 to
5 μl (corresponding to 1 μg) of each specific antibody.
After incubation at 4°C overnight, the beads were washed
5 times with lysis buffer (50 mM Hepes-KOH, pH 7.5,
60 mM KCl, 2.5 mM EDTA, and 0.1% Triton X-100). Pro-
teins were eluted by boiling the beads and were separated
with SDS-PAGE for after Western blotting detection.RNA extraction and qPCR analysis
Total cellular RNA was isolated by using the ISOGEN
(Wako). RNA from dissected DG of HPC was purified
with ISOGEN after homogenization (Microson, Heat
Systems). Total RNA was treated RNase-free DNase I
(Ambion, Life Technologies Japan Ltd., Tokyo, Japan).
First-strand cDNA synthesis was carried out by follow-
ing the manufacturer’s protocol (Invitrogen, Life Tech-
nologies Japan Ltd., Tokyo, Japan; Takara Bio Inc., Shiga,
Japan). Quantitative PCR was performed by using the
SyBr Green method (Applied Biosystems; 4309155) and
standard 35 to 40 cycles by using the ABI qPCR ma-
chine. GAPDH was used as an internal control.
The ΔΔCT method of relative quantification was used
to determine the fold change in gene expression. The
ΔΔCT calculation was done by first normalizing the re-
sulting threshold cycle (CT) values of the target mRNAs
to the CT values of the internal control GAPDH in the
same samples (ΔCT = CTTarget - CTGAPDH ). It was
further normalized with the control (ΔΔCT = ΔCT -
CT Control). The fold change in expression was then
obtained (2-ΔΔCT).Statistics
All experiments were analyzed for statistical significance
by using a Student t test, with all error bars expressed
as ± standard error of the mean (SEM). Values of P < 0.05
were considered significant.









































































Figure 1 Changes in the DG expressions of genes controlling
adult HPC neurogenesis during diabetes progression. On
the day 5 of streptozotocin (STZ)-induced hyperglycemia, the
brains were removed quickly, and the dentate gyrus (DG) region
was microdissected to extract total RNA. For qPCR analysis,
RNAs from the DG of control (n = 6) and diabetic rats (n = 6)
were extracted and were subjected to qPCR analysis of gene
expression of Sox2 and Nestin (stem cell marker genes), NeuroD1
(insulin-activating gene), insulin (proinsulin1), β-tubulin III (TUBB3,
immature neuron marker gene), SYN1 (mature neuron marker
gene), GFAP, GLIT1, SC1, and BYSL (astrocyte-marker genes). RNA
samples were also prepared from rats 2 weeks and 2 months
after the STZ induction.
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Effects of diabetes on OB and HPC tissues: time-course
analysis of gene expression required for insulin
expression and neuronal differentiation after induction of
diabetes by STZ
Intraperitoneal injection of STZ caused the development
of pronounced hyperglycemia in experimental animal
[29]; the blood glucose levels of STZ-induced rats were
greater than 300 mg/dl on the third day after the injec-
tion. On day 5 of STZ-induced hyperglycemia, the brains
were removed quickly, and the DG region was micro-
dissected to extract total RNA. For qPCR analysis, RNAs
from the DGs of control and diabetic rats were extracted
and were subjected to qPCR to analyze the expression of
Sox2, Nestin, NeuroD1, insulin, beta-tubulin III (TUBB3),
synapsin 1 (SYN1), glial fibrillary acidic protein (GFAP),
GLIT1, SC1, and bystin-like (BYSL, astrocyte marker
genes) [31]. RNA samples were also prepared from rats
2 weeks and 2 months after STZ induction to observe
changes in the gene-expression profiles, depending on the
time course of STZ-induced diabetes.
Expression of Sox2 and Nestin mRNA was similar in
control rats (WT) and STZ-induced diabetic rats (DB)
on day 5 (top panel in Figure 1; relative expression in
DB samples/WT sample (%)). Additionally, the expression
of astrocytic genes was unchanged (GFAP, GLIT1, SC1,
and BYSL). However, reduced expression of NeuroD1 and
insulin transcripts in the hippocampal DG was observed
during the early progression of diabetes (5 days after STZ
induction; Figure 1, top panel). The reduced expression of
these targets was maintained at both the 2-week (middle
panel, Figure 1) and 2-month time points (bottom panel,
Figure 1), indicating that diabetes progression was asso-
ciated with a decline in insulin expression in the hippo-
campal DG.
After the significant reduction of NeuroD1 and insulin
mRNA expression in the DG of diabetic rats (*P = 0.01;
**P = 0.001; Figure 1), the expression of neuronal genes
such as TUBB3 and SYN1 was also decreased. However,
the expression of astrocytic genes remained unchanged,
suggesting that diabetes caused inhibitory effects on the
differentiation of NSCs into neuronal lineages. Because
NeuroD1 is indispensable for triggering neuronal differ-
entiation in adult hippocampal NSCs [32,33], the decline
in NeuroD1 expression may directly affect neuronal dif-
ferentiation and influence mature neuronal genes, such
as SYN1. Additionally, because NeuroD1 is necessary for
insulin expression in adult NSCs via direct transcrip-
tional activation of the bHLH transcription factor [29], a
reduction in insulin expression would be expected to
occur simultaneously. Moreover, insulin is known to
promote the function of FGF-2, indicating that insulin
also enhances and supports the self-renewal ability of
stem cells. Therefore, the reduction in insulin expressionin diabetes at early time points may indirectly inhibit the
function of the stem cell population.
The expression of Sox2 and Nestin transcripts (stem
cell marker genes) was reduced at the 2-month time
point (bottom panel, Figure 1), suggesting that diabetes
caused impairment of adult neurogenesis, consistent
with previous study [24]. Diabetes-mediated inhibition
of stem cell abilities in the HPC is probably associated
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Sox2 protein is critical for maintaining NSC function
(both proliferation and self-renewal abilities) [5,34-36].
Moreover, the involvement of Sox2 in the regulation
of NeuroD1 via the Sox/LEF regulatory system and
Sox2-mediated suppression of genes is required for dif-
ferentiation in undifferentiated NSCs and for Wnt (TCF/
LEF)-mediated activation of such genes [32].
Effects of diabetes on OB and HPC NSCs cultures: the
establishment of adult NSCs from the OB and HPC of rats
during the early phase of diabetes progression
The predominant effects of diabetes progression on neu-
ronal differentiation were observed in vivo with qPCR
analysis by using hippocampal DG samples collected at
early time points (that is, 5 days to 2 weeks after STZ in-
duction; Figure 1). We established adult NSC cultures
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Figure 2 Differentiation abilities of adult NSCs derived from HPC and
OB of diabetes rats. The adult NSCs isolated from HPC of control wild-type
NSCs isolated from OB are shown in right panels. In vitro differentiated adu
was exposed to neuron-differentiation conditions (RA + FSK + KCl), both H
(IHC) of the adult NSCs isolated from HPC (left) and OB (right) of control w
Sox2 (red), Map2AB (green) are shown in the upper panels. IHC images usitype) and STZ-induced diabetic rats (DB) at 10 days
after induction. To investigate the utility of OB-derived
adult NSCs for monitoring potential changes that may
reflect diabetes-mediated neurodegeneration in the CNS,
we established adult NSC cultures from the OB of WT
and diabetic rats at the same time point (10 days after
the induction).
In parallel, adult HPC- and OB-derived NSC cultures
were maintained in 20 ng/ml FGF-2 (Figure 2). Adult
NSC cultures established from the hippocampal DG
from WT or diabetic animals exhibited similar morpho-
logies (NSC; Figure 2A). HPC NSCs from both groups
of rats were round and retained their shapes when
expanded as a monolayer. HPC and OB NSCs derived
from WT rats expressed Sox2 transcripts, but Sox2
expression was more obvious in NSCs derived from WT
rats than in those derived from diabetic rats (Figure 2B).
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OB of diabetes rats. (A) Adult NSCs cultures derived from HPC and
rats (WT) and diabetes (DB) rats are shown in left panels. The adult
lt HPC- and OB neurons are also shown (Neuron). When the culture
PC and OB cells extended neuritis. (B) Immunohistochemistory analysis
ild-type rats (WT) and diabetes (DB). IHC images using antibodies of
ng antibodies of GFAP (red), TUJ1 (green) were shown in lower panels.
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treated with the FGF-2 ligand did not enter neuronal
differentiation (Figure 2B).
Under neuronal differentiation conditions (Neuron),
the cell morphologies changed markedly, and extended
neurites were observed (Figure 2A). In HPC neuron
cultures from WT animals (WT HPC neuron), multiple
neurites were generated from a cell body, and they were
extended in various directions in a complex manner. In
contrast, in HPC neurons derived from diabetic animals
(DB HPC neuron), fewer neurite connections were created
than those observed in WT HPC neurons (Figure 2A).
The differentiation properties of WT HPC neurons and
diabetic HPC neurons were also evaluated by using IHC
analysis. In the NSC state, NSCs from both the WT HPC
and the diabetic HPC exhibited positive signals for Sox2
in their nuclei, whereas Map2ab staining was negative
(Figure 2B), indicating that these NSCs were retained in
the undifferentiated stem cell state. In contrast, after neur-
onal differentiation, neurons from both the WT HPC and
the diabetic HPC expressed TUJ1, but not GFAP, indi-
cating that these cells had successfully committed to neu-
ronal differentiation lineages. Notably, the intensity of
the TUJ1-positive signal was stronger in neurons from
the WT HPC than in neurons from the diabetic HPC
(Figure 2B).
OB NSCs from WT or diabetic rats grew as heteroge-
neous cultures with adherent properties and neuros-
phere morphologies (Figure 2A). In OB NSCs from
diabetic animals (DB OB NSC), neurospheres formed
with inconsistent shapes and sizes, and dying cells
(single cells) were more frequently observed than in OB
NSC cultures from control animals (WT DB NSC). The
adherent properties of OB NSCs from diabetic rats
seemed weaker than those of OB NSCs from WT rats
(Figure 2A). In OB neuron cultures from WT animals,
multiple and prolonged neurites were generated from
clusters of cells (WT OB neuron, Figure 2A). WT OB
neurons differentiated from WT OB NSCs in vitro
exhibited extended neurites that were positive for TUJ1
in IHC analysis (Figure 2B). In contrast, OB neurons dif-
ferentiated from diabetic OB NSCs (DB OB neurons)
created thinner and shorter neurites from the cell body
than those observed in WT OB neurons (Figure 2B).
IHC analysis of OB neurons derived from diabetic rats
indicated that these cells had difficulties with neuronal
differentiation because few TUJ1-positive neurons were
found in the culture (Figure 2B).
These results suggest that diabetes caused inhibitory
effects on the neurogenesis of adult NSCs in both in vivo
and in vitro cultures derived from the HPC and OB of
diabetic animals. Adult NSC cultures were established at
early period during the progression of diabetes (10 days
after the STZ induction), and this early time point wassufficient for the detection of differences in the function
of adult NSCs between WT and diabetic rats. Differences
became clearer when NSCs derived from diabetic rats
were differentiated into neuronal lineages, both in the
HPC and DB (Figure 2).
Identification of diabetes-response genes in adult OB and
HPC NSCs derived from the early phase of diabetes
progression: Wnt signaling-related molecules
To determine specific genes that may account for the
differences in the neuronal differentiation of diabetic
NSCs and WT NSCs, we next conducted comparative
qPCR analysis. NSCs derived from the WT and diabetic
HPC and OB were differentiated simultaneously into
neuronal lineages, and total RNA was extracted 24 hours
after the neuronal induction (NP, neuronal progenitor
stage). Our previous microarray study indicated the
general gene profiles that are up- or downregulated on
neuronal induction in adult NSCs (and subsequently
formed neurons) [29]. Genes responding similarly in
NSCs from both the HPC and OB at early phases
of diabetes progression have the potential to be used
as marker genes in monitoring disease-associated
alterations of HPC cells by using OB NSC cultures
(Figure 3).
After neuronal differentiation, as described earlier, the
expression of NeuroD1 and insulin transcripts was re-
duced specifically in OB and HPC NSC cultures derived
from diabetic rats (Figure 3A). Because the activation
of NeuroD1 mRNA expression requires Wnt signaling
[29,32], we examined the intracellular expression of
Wnt-related molecules in our analysis. The frizzled (Fzd)
receptor is associated with a transmembrane protein
called low-density lipoprotein receptor-related protein
(LRP) in Wnt signal transduction. Wnt signaling
through Fzd and LRP receptor pairs activates dishe-
velled (Dvl) and inhibits glycogen synthase kinase
(GSK) 3β, and then stabilizes β-catenin. The expres-
sion of Fzd1, LRP1, Dvl1, Dvl2, β-catenin, and GSK3β
mRNAs was almost unchanged between diabetic and
WT samples in both OB and HPC NSC cultures un-
der the neuronal differentiation conditions used in this
study (Figure 3A).
From qPCR analysis, we found that the expression of
Fzd3 and LRP5 mRNAs was coordinately downregulated
in both OB and HPC cultures, specifically in samples de-
rived from diabetic rats. Fzd3 is a transmembrane recep-
tor for secreted Wnt glycoproteins involved in the Wnt
signal-transduction cascade. Association studies have
shown that the Fzd3 gene plays an important role in
underlying schizophrenia [37]. Our data suggest that
Fzd3 may be involved in Wnt signaling pathways that
influence the expression of NeuroD1 [29,32] in adult




















































































Figure 3 Identification of diabetes-response genes in adult OB
and HPC neurons. (A) qPCR analysis of diabetes-response genes
related to Wnt signaling. WT (wild-type) HPC NSCs, DB (diabetic)
HPC NCSs, WT OB NSCs, and DB OB NSCs were differentiated
simultaneously into neuronal lineages, and the total RNAs were
extracted 24 hours after the neuronal induction (neuronal progenitor
stage; NP). (B) qPCR analysis of diabetes-response genes in OB and
HPC neurons. (C) Western blotting analysis of diabetes-response
genes. Nrxn1 (neurexin 1) exhibited DB-specific downregulation
(top). Similarly, Scn1b (sodium channel, voltage-gated, type I, β
subunit) shows diabetes-associated reduction (middle). Relative band
intensity of each protein in the Western blotting analysis is shown
on the right.
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in the Wnt-signaling cascade and is genetically associ-
ated with type 1 diabetes [38]. Polymorphisms in the
promoter region of LRP5 are associated with diabetes
[38], and alterations in LRP5 expression may be res-
ponsible for diabetes susceptibility [38,39]. The reduc-
tion in LRP5 expression in both OB and HPC NSC
cultures derived from diabetic animals implied that
LRP5 may influence the neurodegenerative phenotypein the CNS, especially in the HPC and OB under dia-
betic conditions.
Diabetes-response genes in adult OB and HPC NSCs
during neuronal differentiation: potential marker genes
to detect the malignancy of CNS function by using adult
NSCs derived from the OB
Among many neuronal lineage-specific genes expressed
in hippocampal neurons, most are equally expressed in
OB neurons. Cask (calcium/calmodulin-dependent serine
protein kinase), SSH (sonic hedgehog), Snai1 (snail homo-
log 1, zinc finger protein), and Nid2 (nidogen 2; basement
membrane proteins) were highly expressed in both OB
and HPC neurons in vitro, consistent with microarray
analysis of in vitro cultures of OB and HPC neurons [29],
and the expression levels of these targets were similar
between diabetic and WT samples (Figure 3B).
From qPCR analysis, we identified five diabetes-
response genes in adult NSCs that were similarly altered
(that is, either increased or decreased) during neuronal
differentiation in OB and HPC in vitro cultures. Nrxn1
(neurexin 1), Scn1b (sodium channel, voltage-gated, type
I, β subunit), Scn4b (sodium channel, voltage-gated, type
IV, β subunit) and Nupr1 (nuclear protein 1) transcripts
were downregulated only in OB and HPC neurons
derived from diabetic rats. Nrxn1 belongs to a neurexin
family of proteins that function in the vertebrate nervous
system as cell-adhesion molecules and receptors. Mu-
tation of the Nrxn1 gene has been associated with schi-
zophrenia, autism, intellectual disability, and type 1
diabetes [40]. Western blotting analysis with specific
antibodies against Nrxn1 and Scn1b revealed that the
observed diabetes-associated reduction in Nrxn1 and
Scn1b mRNA expression in HPC and OB neurons was
also seen at the protein level (Figure 3C).
Overexpression of the Nupr1 gene has been shown to
enhance glucose-stimulated β-cell proliferation and insu-
lin secretion in primary human islets [40-43], indicating
that the primary role of the Nupr1 gene is the regulation
of insulin in pancreatic endocrine cells. The adult CNS
(neurons) and endocrine system (β cells) share common
transcription factors, such as NeuroD1, that are required
for insulin expression [29]. They also use similar cellular
signaling pathways (that is, Wnt signaling is required for
the activation of the NeuroD1 gene) via the secretion of
Wnt3 from their niches (astrocytes and α cells) [29,44].
Diabetes-specific downregulation of Nupr1 transcripts in
adult OB and HPC neurons at early phases of diabetes
progression suggest that Nupr1 affects and accelerates
the dysregulation of insulin-mediated intra- and intercel-
lular networks in the CNS, promoting the pathogenesis
of neurodegenerative disorders.
In contrast, excitatory amino acid transporters (EAATs),
also known as glutamate transporters, were highly
CWT    DB
-Insulin IP
EAAT3
WT    DB
-EAAT3 IP
Insulin
Figure 4 Upregulated EAAT3 interacts with insulin under diabetes in HPC. (A) IHC of HPC neurons in molecular layer at DG of WT
(wild-type) and DB rats. IHC images using antibodies of EAAT3 (red) and Insulin (green) are shown. (B) Magnified image at dotted-line area in
Figure 4A is shown in separate panels. (C) Immunoprecipitation (IP) analysis of EAAT3 and insulin. The association between EAAT3 and insulin
was specifically observed in the HPC from diabetic rats when EAAT3 expression was highly upregulated.
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from diabetic NSCs (Figure 3B). Our subsequent IHC ana-
lysis of EAAT3 in the HPC (Figure 4) and OB (Figure 5)
revealed colocalization of EAAT3 and insulin proteins
specifically in diabetic animals. Compared with WT rats
(Figure 4A, upper panels), diabetic rats exhibited reduced
insulin expression and secretion in the DG region of
the HPC (Figure 4A, lower panels), and detected signals
were almost completely colocalized with EAAT3 proteins,
which were highly upregulated in the diabetic HPC.
Magnified confocal images of IHC sections indicate that
EAAT3 and insulin colocalized specifically in the diabetic
HPC (Figure 4B, right panels) and that, although HPC
cells derived from WT rats expressed higher levels of
insulin, this upregulated insulin did not colocalize with
EAAT3 (Figure 4B, left panels).In IHC analysis of OB tissues from both WT and
diabetic rats, we observed similar alterations in the ex-
pression of EAAT3 protein. In the WT OB, insulin was
highly expressed, whereas EAAT3 was expressed at low
levels (Figure 5A, upper panels, and Figure 5B, left panels).
In contrast, the OB from diabetic rats exhibited upregu-
lation of EAAT3 protein, and EAAT-positive signals were
partly colocalized with those of insulin (Figure 5A, lower
panels, and Figure 5B, right panels). Diabetes-specific
colocalization of EAAT3 and insulin was further examined
by immunoprecipitation analysis (IP). Pulled-down frac-
tions of HPC and OB lysates with monoclonal anti-insulin
antibodies demonstrated that EAAT3 interacted with
insulin specifically in diabetic samples (Figures 4C
and 5C). Similarly, pulled-down fractions of HPC and
OB lysates with anti-EAAT3 antibodies demonstrated
CWT    DB
-Insulin IP
EAAT3
WT    DB
-EAAT3 IP
Insulin
Figure 5 Upregulated EAAT3 interacts with insulin in diabetes in OB. (A) IHC analysis of EAAT3 and Insulin in OB. IHC images using
antibodies of EAAT3 (red) and Insulin (green) are shown. (B) Magnified image at dotted line area in Figure 5A is shown in separate panels. (C) IP
analysis of EAAT3 and insulin in OB. The association between EAAT3 and insulin was specifically observed in the OB from diabetic rats when
EAAT3 expression was highly upregulated.
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ples (Figures 4C and 5C). Our IP analysis suggested
that EAAT3 protein could bind to and capture insulin
in the diabetic state. This association between EAAT3
and insulin was specifically observed in the HPC and
OB from diabetic rats when EAAT3 expression was
highly upregulated (Figures 4C and 5C).
Functions of glutamate transporters include regulation
of excitatory neurotransmission, maintenance of low am-
bient extracellular glutamate concentrations to protect
against neurotoxicity, and providing glutamate for me-
tabolism through the glutamate-glutamine cycle. Hyper-
activity of glutamate transporters has been implicated in
the pathophysiology of schizophrenia and other mentalillnesses [45]. In the pancreatic islets of Langerhans, glu-
tamate is proposed to act as an intracellular messenger,
regulating insulin secretion from β cells. EAAT regulates
the pH and membrane potential of the granules and
thereby regulates insulin secretion in pancreatic β cells.
Increased EAAT expression during the progression of
diabetes in adult OB and HPC neurons (Figures 3, 4 and
5) may cause not only unbalanced glutamate-mediated
transmission in the CNS but also the dysregulation of
insulin secretion from neurons [29]. Our data may
therefore be important for understanding the novel
functions of identified genes associated with diabetes-
related neurodegenerative disorders in the CNS in future
studies.
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Adult NSCs extracted from the OB and HPC of diabetic
rats at early phases of diabetes progression can be
expanded in in vitro cultures. Thus, because OB NSCs
reacted similar to HPC NSCs in terms of differentiation
potential and gene expression, these cells represent a
useful tool to investigate the neurogenic functions of the
CNS and to develop potential drugs for the treatment of
clinical disorders. In particular, Nrxn1 and Scn1b tran-
scripts were downregulated, whereas EAAT3 protein
and mRNA were upregulated in both the HPC and OB
of diabetic rats. These alterations suggest that the HPC
and OB may exert similar influences on the progression
of diabetes.
In future studies, elucidating the pathology of diabetes-
mediated neurodegenerative disorders, neurologic disea-
ses, and mental illnesses, the risks of which increase as the
pathology of diabetes progresses, or searching for new
therapeutic reagents for the treatment of diabetes itself
and developing novel treatment techniques may all be
facilitated through the use of NSCs derived from the OB.
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